期刊文献+

大肠杆菌表达人幽门螺杆菌尿素酶B亚单位跨膜区成份 被引量:6

Recombination and expression of a component of urease B subunit transmembrane protein of helicobacter pylori
下载PDF
导出
摘要 目的重组表达人幽门螺杆菌尿素酶 B亚单位跨膜区成份。方法采用 DNA重组技术将尿素酶 B亚单位 3'端732 bp基因片段克隆至 p ET11C载体上 ,转化宿主菌 BL 2 1(DE3) E.coli,IPTG诱导 ,SDS- PAGE及 Western- blot分析表达情况。结果成功构建了含 Ure B0 .7kb片段的重组质粒 p ET- Ure B0 .7,并表达了具有免疫反应性的分子量约 2 80 0 0 u的重组蛋白 ,表达率为 19.8%。结论重组的尿素酶 B亚单位跨膜区成份为研究其相关生物学特性奠定了重要基础 ,亦可作为 Hp疫苗的成分用于 ObjectiveTo recombine and express a component of urease B subunit transmembrane protein of helicobacter pylori MethodsA 732 bp gene fragment of urease B subunit of helicobacter pylori was cloned into pET11C and transformed into BL21(DE3) E coli The positive clone was induced with IPTG The expression of target protein was analysed by SDS PAGE and Western blot ResultsIt is successful to construct the recombinant plasmid pET UreB0 7 containing urease B subunit 0 7 kb gene fragment A protein (MW≈28 000 u) with immunoreactivity, was expressed by 19 8% in BL21(DE3) E coli induced with IPTG ConclusionsThe recombinant component of urease B subunit transmembrane protein may play a role in the research of its biological function and might be used as the vaccine against helicobacter pylori
出处 《免疫学杂志》 CAS CSCD 北大核心 2001年第2期94-96,共3页 Immunological Journal
基金 国家"九五"重点攻关课题!(96 - 90 1- 0 1- 5 4) 军队"九五"医药卫生科研基金!(98D0 44 )资助项目
关键词 幽门螺杆菌 大肠杆菌 尿素酶B亚单位 基因重组 跨膜区成份 DNA helicobacter pylori B subunit of urease transmembrane protein DNA recombination
  • 相关文献

参考文献3

  • 1丁·萨姆布鲁克 EF·弗里奇 等.分子克隆实验指南(第2版)[M].北京:科学出版社,1992.34-55.
  • 2Gomez D G,Vaccine,1998年,16卷,5期,460页
  • 3金冬雁(译),分子克隆实验指南(第2版),1992年,16页

共引文献1

同被引文献27

  • 1颜子颖 王海林(译).精编分子生物学实验指南[M].北京:科学出版社,1999.480-487.
  • 2毛旭虎.幽门螺杆菌尿素酶及亚单位疫菌的实验研究.第三军医大学博士论文[M].,2001.36-40.
  • 3[1]Feldman R A, Eccersley A J, Hardie J M. Epidemiology of Helicobacter pylori: acquisition, transmission, population prevalence and disease-to-infection ratio[J]. Br Med Bull, 1998, 54(1): 39-53.
  • 4[2]范工学,夏华向. 幽门螺杆菌感染--基础与临床[M]. 长沙:湖南科学技术出版社,1997.38-47.
  • 5[5]Czinn S J, Nedrud J G. Oral immunization against Helicobacter pylori[J]. Infect Immun, 1991,59(7): 2359-2363.
  • 6[6]Corthesy-Theulaz I, Porta N, Glauser M, et al. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice[J]. Gastroenterology, 1995,109(1): 115-121.
  • 7[1]Luzza F, Maletta M, Imeneo M, et al. Salivary-specific immunoglobulin G in the diagnosis of Helicobacter pylori infection in dyspeptic patients[J]. Am J Gastroenterol,1995,90(10):1 820-1 823.
  • 8[10]Blanchard TG, Czinn SJ, Nedrud JG, et al . Host response and vaccine development to Helicobaeter pylori infection[J]. Curr Top Microbiol Immunol,1999,241(2):181-213.
  • 9[11]Labigne A, Reuse HD. Determinants of Helicobacter pylori pathogenicit1y[J]. Infect Agents Dis,1996,5(4):191-202.
  • 10Sunitha K,Chung BH,Jang KH,et al.Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli. Protein Expr Purif,2000,18(3):388-393.

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部